FindTrial
Sign In

Role of Homoeopathic Medicines in patients with Oral Submucosal Fibrosis

Role of Homoeopathic Medicines in improving quality of life in Oral Submucous Fibrosis (OSMF) in adults using OHIP-14 Tool- A Prospective Interventional Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100262
Enrollment
40
Registered
2026-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

Intervention1: Indivualised Homoeopathic Medicines: Indivualised Homoeopathic Medicines, dose as per requirement of patient with repetition every 15 days. Control Intervention1: Nil: Nil

Sponsors

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University
Lead Sponsor
Dr Dharmarajsinh Raulji
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Prediagnosed cases of OSMF 2 Mild to Severe Restriction of interincisional distance according to Khanna and Andrade classification

Exclusion criteria

Exclusion criteria: 1 Severe Restriction of interincisional distance according to Khanna and Andrade classification 2 Pregnant and lactating women 3 Patient with other confirmed oral malignancy

Design outcomes

Primary

MeasureTime frame
Marked improvement Moderate improvement Mild improvement Status Quo Any increase in OHIP 14 will be considered as worseTimepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Dharmarajsinh Jaydipsinh Raulji

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University

partha.mandal27317@paruluniversity.ac.in9375095471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026